Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 62.45% is in line with its 5-year average of 60.51%, near the high end of its 5-year range (56.97%–64.04%).
0.02% above its 12-month average of 62.44%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 64.04%.
GROSS MARGIN
62.45%
GROSS MARGIN AVG TTM
62.44%
GROSS MARGIN AVG 3Y
61.37%
GROSS MARGIN AVG 5Y
60.51%
GROSS MARGIN AVG 10Y
58.61%
GROSS MARGIN AVG 15Y
57.28%
GROSS MARGIN AVG 20Y
55.84%
CURRENT VS TTM AVG
+0.02%
CURRENT VS 3Y AVG
+1.76%
CURRENT VS 5Y AVG
+3.20%
CURRENT VS 10Y AVG
+6.55%
CURRENT VS 15Y AVG
+9.02%
CURRENT VS 20Y AVG
+11.83%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+5.86%
vs the sector median at left
IDEXX Laboratories, Inc.
Market Cap
$40.15B
Gross Margin
62.45%
TTM Avg
62.44%
3Y Avg
61.37%
5Y Avg
60.51%
Market Cap
$40.24B
Gross Margin
53.73%
TTM Avg
53.36%
3Y Avg
52.95%
5Y Avg
53.14%
Market Cap
$41.92B
Gross Margin
26.23%
TTM Avg
30.59%
3Y Avg
32.75%
5Y Avg
33.07%
Market Cap
$42.43B
Gross Margin
52.47%
TTM Avg
50.27%
3Y Avg
48.88%
5Y Avg
48.29%
Market Cap
$33.67B
Gross Margin
79.72%
TTM Avg
83.69%
3Y Avg
83.53%
5Y Avg
83.62%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $40.15B | 62.45% | 62.44% | 61.37% | 60.51% |
| Agilent Technologies, Inc. (A)vs › | $40.24B | 53.73% | 53.36% | 52.95% | 53.14% |
| IQVIA Holdings Inc. (IQV)vs › | $41.92B | 26.23% | 30.59% | 32.75% | 33.07% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.43B | 52.47% | 50.27% | 48.88% | 48.29% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $33.67B | 79.72% | 83.69% | 83.53% | 83.62% |
| Centene Corp. (CNC)vs › | $32.87B | 16.13% | 11.28% | 11.33% | 11.71% |
| Alcon Inc. (ALC)vs › | $32.68B | 56.45% | 55.42% | 55.20% | 53.33% |
| ResMed Inc. (RMD)vs › | $31.89B | 61.16% | 60.26% | 58.24% | 57.85% |
| Biogen Inc. (BIIB)vs › | $31.74B | 67.71% | 73.30% | 74.61% | 77.63% |
| DexCom, Inc. (DXCM)vs › | $31.63B | 62.47% | 60.28% | 62.12% | 63.92% |
Gross Margin
62.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 64.04% |
| 2026-03-31 | 63.35% |
| 2025-12-31 | 60.35% |
| 2025-09-30 | 61.83% |
| 2025-06-30 | 62.62% |
| 2025-03-31 | 62.44% |
| 2024-12-31 | 59.80% |
| 2024-09-30 | 61.10% |
| 2024-06-30 | 61.87% |
| 2024-03-31 | 61.52% |
| 2023-12-31 | 58.36% |
| 2023-09-30 | 59.85% |
| 2023-06-30 | 60.71% |
| 2023-03-31 | 60.32% |
| 2022-12-31 | 58.53% |
| 2022-09-30 | 60.19% |
| 2022-06-30 | 59.73% |
| 2022-03-31 | 59.62% |
| 2021-12-31 | 56.97% |
| 2021-09-30 | 58.35% |
| 2021-06-30 | 59.23% |
| 2021-03-31 | 60.53% |
| 2020-12-31 | 56.80% |
| 2020-09-30 | 58.55% |
| 2020-06-30 | 59.50% |
| 2020-03-31 | 57.41% |
| 2019-12-31 | 54.70% |
| 2019-09-30 | 56.99% |
| 2019-06-30 | 57.71% |
| 2019-03-31 | 57.56% |
| 2018-12-31 | 54.67% |
| 2018-09-30 | 56.04% |
| 2018-06-30 | 57.24% |
| 2018-03-31 | 56.37% |
| 2017-12-31 | 53.84% |
| 2017-09-30 | 55.69% |
| 2017-06-30 | 57.51% |
| 2017-03-31 | 55.88% |
| 2016-12-31 | 54.32% |
| 2016-09-30 | 55.04% |
| 2016-06-30 | 55.84% |
| 2016-03-31 | 54.49% |
| 2015-12-31 | 54.47% |
| 2015-09-30 | 55.19% |
| 2015-06-30 | 56.31% |
| 2015-03-31 | 56.35% |
| 2014-12-31 | 51.76% |
| 2014-09-30 | 55.63% |
| 2014-06-30 | 56.01% |
| 2014-03-31 | 56.11% |
| 2013-12-31 | 53.28% |
| 2013-09-30 | 54.92% |
| 2013-06-30 | 56.07% |
| 2013-03-31 | 55.40% |
| 2012-12-31 | 52.90% |
| 2012-09-30 | 54.09% |
| 2012-06-30 | 55.02% |
| 2012-03-31 | 54.16% |
| 2011-12-31 | 51.72% |
| 2011-09-30 | 52.72% |
| 2011-06-30 | 54.75% |
| 2011-03-31 | 52.93% |
| 2010-12-31 | 51.02% |
| 2010-09-30 | 52.74% |
| 2010-06-30 | 53.04% |
| 2010-03-31 | 53.02% |
| 2009-12-31 | 49.17% |
| 2009-09-30 | 50.35% |
| 2009-06-30 | 52.10% |
| 2009-03-31 | 52.62% |
| 2008-12-31 | 49.54% |
| 2008-09-30 | 51.04% |
| 2008-06-30 | 53.91% |
| 2008-03-31 | 52.13% |
| 2007-12-31 | 49.90% |
| 2007-09-30 | 51.65% |
| 2007-06-30 | 48.19% |
| 2007-03-31 | 51.42% |
| 2006-12-31 | 50.09% |
| 2006-09-30 | 52.41% |
| 2006-06-30 | 51.75% |
| 2006-03-31 | 51.16% |
| 2005-12-31 | 50.86% |
| 2005-09-30 | 51.45% |
| 2005-06-30 | 50.16% |
| 2005-03-31 | 49.91% |
| 2004-12-31 | 47.76% |
| 2004-09-30 | 52.98% |
| 2004-06-30 | 52.41% |
| 2004-03-31 | 50.25% |
| 2003-12-31 | 48.13% |
| 2003-09-30 | 49.22% |
| 2003-06-30 | 48.97% |
| 2003-03-31 | 47.11% |
| 2002-12-31 | 46.28% |
| 2002-09-30 | 48.56% |
